NFA
HZNP

Nationwide Fund Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Nationwide Fund Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-90,086
Closed -$1.14M – 2825
2017
Q3 		$1.14M Sell
90,086
-11,100
-11% -$141K ﹤0.01% 1709
2017
Q2 		$1.2M Buy
101,186
+6,255
+7% +$77.8K ﹤0.01% 1680
2017
Q1 		$1.4M Sell
94,931
-5,765
-6% -$93.4K 0.01% 1573
2016
Q4 		$1.63M Sell
100,696
-4,959
-5% -$89.9K 0.01% 1507
2016
Q3 		$1.92M Hold
105,655
– – 0.01% 1410
2016
Q2 		$1.74M Buy
+105,655
New +$1.71M 0.01% 1432
2015
Q2 		– Sell
-47,632
Closed -$1.24M – 3385
2015
Q1 		$1.24M Sell
47,632
-1,586
-3% -$29.1K 0.01% 1784
2014
Q4 		$634K Sell
49,218
-566
-1% -$7.08K ﹤0.01% 2044
2014
Q3 		$611K Sell
49,784
-132,778
-73% -$1.54M ﹤0.01% 2086
2014
Q2 		$2.89M Buy
182,562
+61,523
+51% +$878K 0.01% 1268
2014
Q1 		$1.83M Buy
121,039
+81,377
+205% +$919K 0.01% 1416
2013
Q4 		$302K Sell
39,662
-1,036
-3% -$5.59K ﹤0.01% 2484
2013
Q3 		$138K Buy
40,698
+7,839
+24% +$20.7K ﹤0.01% 2842
2013
Q2 		$81K Buy
+32,859
New +$78.8K ﹤0.01% 2861

Other funds holding HZNP

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's HZNP Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2017, closing a stake of 90,086 shares — an estimated $1.14M sold.

Nationwide Fund Advisors first reported a position in HZNP in Q2 2013 and held it in 14 quarters. The position peaked at $2.89M in Q2 2014. 183 funds tracked by Wall St. Rank hold HZNP as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 90,086 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2017, an estimated $1.14M.
  • Nationwide Fund Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 14 quarters.
  • Nationwide Fund Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.89M in Q2 2014.
  • 183 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.